Daniel Paul Regan, Chief Commercial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 9,847 shares at $208.08 ($2.0M) on 2015-01-30, disclosed to the SEC on 2015-02-03.
Scheduled sale ($2.0M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.07 | 6,847 | $1.4M | 69.2% |
| 2 | $201.50 | 1,207 | $243K | 12.3% |
| 3 | $202.49 | 793 | $161K | 8.1% |
| 4 | $205.87 | 800 | $165K | 8.3% |
| 5 | $208.08 | 200 | $42K | 2.1% |
| Total | $201.07 avg | 9,847 |
| $2.0M |
| 100% |
| Filing → |
| ICPT | SELL | 2014-07-08 | $250 | — | Filing → |
| ICPT | SELL | 2014-03-07 | $8.7M | — | Filing → |